Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma
NCT04319874Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- HM (Herbal Medicine), Nutraceutical
01
Overview
A Phase 2 trial of ganoderma lucidum in osteosarcoma (OS), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
ganoderma lucidum
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT04319874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04319874.